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Case Report
Late  in-stent  restenosis  after  sirolimus-eluting  stent
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formation—–Insight  from  a  case  with  IVUS,  OCT,  and
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Summary  We  experienced  a  case  of  very  late  in-stent  restenosis  of  a  sirolimus-eluting  stent
(SES) (3.0  mm  ×  18  mm)  in  the  left  anterior  descending  coronary  artery  in  a  62-year-old  man
with type  2  diabetes  mellitus,  dyslipidemia,  and  hypertension.  Angina  pectoris  recurred  39
months after  the  index  percutaneous  coronary  intervention  (PCI).  We  performed  PCI  with  optical
coherence  tomography  (OCT)  and  intravascular  ultrasound  (IVUS)  guidance.  OCT  showed  very
eccentric low  signal  plaque  with  a  high  signal  thin  cap  on  the  delayed  healing  stent  struts
without intimal  coverage.  IVUS  showed  that  the  plaque  was  eccentric  and  hypoechogenic  with
a ‘‘black  hole  appearance.’’  We  used  a  ﬁlter  wire  (FiltrapTM,  Nipro,  Osaka,  Japan)  to  prevent
distal embolism.  Filter  no-reﬂow  occurred  after  predilatation.  We  deployed  a  paclitaxel-eluting
stent followed  by  postdilatation.  After  aspiration  and  FiltrapTM withdrawal,  thrombolysis  inultrasound
myocardial  infarction  3  ﬂow  was  obtained.  Histopathological  analysis  revealed  that  the  main
tissue was  composed  of  ﬁbrin  deposits  with  scarce  inﬂammatory  cells  and  proteoglycans.  This
case revealed  that  ﬁbrin  formation  is  related  to  very  late  in-stent  restenosis  and  OCT  and  IVUS
characteristics  of  this  case  are  s
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ase report 62-year-old  man  with  multiple  coronary  risk  factors  pre-
ented  to  our  hospital  because  of  worsening  effort  angina.
e  underwent  index  percutaneous  coronary  intervention
PCI)  for  the  75%  stenosis  in  the  proximal  left  anterior
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Figure  1  (A)  Follow-up  coronary  angiography  at  39  months  (RAO  caudal  view)  arrows  1—3  indicate  corresponding  cross  sections
of the  OCT  ﬁndings  in  (D—F).  (B)  Follow-up  coronary  angiography  at  39  months  (AP  cranial  view).  (C)  Control  coronary  angiography
before PCI  two  months  after  the  diagnostic  coronary  angiography  (AP  cranial  view).  There  was  no  progression  of  stenosis  in  the
proximal LAD  during  the  two  months.  (D)  OCT  ﬁndings  before  PCI  in  the  proximal  stenosis  (arrow  1  in  A).  (E)  OCT  ﬁndings  before  PCI  in
the distal  stenosis  (arrow  3  in  A).  (F)  OCT  ﬁndings  before  PCI  in  the  distal  stenosis  (arrow  2  in  A).  (G)  IVUS  ﬁndings  before  PCI.  RAO,
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Light anterior  oblique  view;  AP,  anterioposterior;  PCI,  percuta
VUS, intravascular  tomography;  LAD,  left  anterior  descending  
escending  coronary  artery  (LAD)  with  sirolimus-eluting
tent  (SES)  (3.0  mm  ×  18  mm)  implantation  in  November
006.  A  follow-up  coronary  angiography  performed  in  August
007  showed  no  restenosis.  He  had  been  asymptomatic  until
e  felt  chest  oppression  both  on  effort  and  at  rest  in  October
009.  He  was  referred  to  our  hospital  in  December  2009
ue  to  prolonged  chest  oppression.  Coronary  angiography
evealed  90%  in-stent-restenosis  (ISR)  of  the  SES  in  January
010  (Fig.  1A  and  B).  This  ISR  lesion  had  two  tandem  stenoses
n  the  stent.  The  patient  was  continued  on  dual  antiplatelet
herapy  (aspirin  and  ticlopidine).
PCI  was  performed  using  both  intravascular  ultrasound
IVUS)  and  optical  coherence  tomography  (OCT)  in  March
010,  two  months  after  the  diagnostic  coronary  angiogra-
hy.  The  angiographic  stenosis  and  morphology  of  this  ISR
id  not  change  for  two  months  (Fig.  1C).  OCT  and  IVUS  were
erformed  before  PCI.  OCT  revealed  that  the  predominant
eature  of  the  restenotic  tissue  structure  was  heterogeneous
ith  low  backscatter  according  to  the  classiﬁcation  of  Gon-
alo  et  al.  [1].  A  superﬁcial  high  signal  cap  (Fig.  1D)  and
ncovered  stent  struts  (Fig.  1E)  were  also  identiﬁed.  We
ivided  this  heterogeneous  restenotic  tissue  into  two  pat-
erns  based  on  the  backscatter  features  and  thickness  of  the
brous  cap.  The  majority  of  tissue  in  the  restenotic  areas
as  located  in  both  proximal  and  distal  stenoses,  where
ackscatter  was  low  and  backward  stent  struts  could  be
dentiﬁed.  On  the  other  hand,  in  the  very  short  segment
2-mm  long  proximal  part  of  the  distal  stenosis)  (Fig.  1F),
here  was  a  whole  circular  thin  cap  ﬁbroatheroma  (TCFA)
ith  very  low  backscatter  completely  hiding  the  stent  struts
uggesting  lipid-laden  plaque  [2].  There  was  no  intralumi-
al  material  protruding  into  the  vessel  lumen.  The  IVUS
nding  was  low  echoic,  including  a  very  low  part,  suggest-
ng  a  ‘‘black  hole  appearance’’  (Fig.  1G)  at  a  point  almost
t
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ary  artery.
dentical  to  arrow  2  in  Fig.  1A.  IVUS  could  not  discriminate
he  two  features  of  restenotic  tissue  observed  by  OCT.  Based
n  these  ﬁndings,  we  suspected  this  lesion  may  be  a  vulnera-
le  plaque  and  decided  to  use  a  ﬁlter  wire  (FiltrapTM,  Nipro,
saka,  Japan)  to  prevent  distal  embolism.  With  a  FiltrapTM
laced  in  the  distal  LAD,  predilatation  was  performed  result-
ng  in  ﬁlter  no  reﬂow.  We  deployed  a  paclitaxel-eluting
tent  (Taxus  LibertyTM, Boston  Scientiﬁc,  Natick,  MA,  USA)
tent  (3.0  mm  × 20  mm)  and  postdilated  with  a  high  pressure
alloon.  After  aspiration  and  FiltrapTM withdrawal,  throm-
olysis  in  myocardial  infarction  (TIMI)  3  ﬂow  was  restored
ithout  slow  ﬂow  or  a  distal  embolism.  No  electrocardio-
raphic  changes  or  creatine  phosphokinase  elevation  was
bserved  on  the  next  day.  Special  staining  and  immuno-
istological  examination  of  collected  material  revealed  it
onsisted  mainly  of  a  ﬁbrin  thrombus  with  scarce  proteogly-
ans  and  no  smooth  muscle  cells  (Fig.  2A—F).
iscussion
n  this  case  report  we  showed  the  OCT  and  IVUS  ﬁndings
f  very  late  ISR  after  SES  implantation  which  was  mainly
omposed  of  ﬁbrin  thrombus  by  the  pathological  analysis  of
etrieved  tissue.
The  phenomenon  of  late  ISR  is  rather  infrequent,  occur-
ing  in  2.6%  of  treated  lesions  [3],  but  has  a  steady
nnual  rate  after  SES  implantation.  The  mechanisms  of  the
ate  catch-up  phenomenon  are  incompletely  understood.
ong-term  inﬂammation  has  been  reported  after  SES  implan-
ation  by  pathological  observation  in  humans  [4].  Since  the
irolimus  is  eluted  from  the  stent  completely  within  about
20  days,  this  inﬂammation  might  be  due  to  polymer  toxic-
ty  or  hypersensitivity.  We  speculated  that  inﬂammation  and
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Figure  2  Materials  retrieved  on  the  FiltrapTM.  After  the  procedure,  the  net  of  the  FiltrapTM was  cut  and  ﬁxed  in  formalin.
The main  samples  captured  on  the  net  were  stained  with  hematoxylin—eosin  staining,  special  staining,  and  immunohistological
staining. (A)  Microscopic  ﬁndings  of  main  retrieved  samples.  (B)  Hematoxylin—eosin  stain:  ×200.  The  retrieved  samples  consisted  of
hypocellular deposits  and  were  mainly  composed  of  ﬁbrin  deposits  with  a  few  inﬂammatory  cells  (neutrophils).  (C)  Phosphotungstic
acid hematoxylin  staining  (PTAH):  ×200.  Fibrin  deposits  were  conﬁrmed  by  PTAH  staining  as  blue.  (D)  Masson  Trichrome  staining:
×200. Fibrin  deposits  were  also  conﬁrmed  by  this  special  staining  as  red.  (E)  Alcian  blue  staining:  ×200.  Proteoglycans  were
200.
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tonly slightly  detected.  (F)  Immunoreactivity  to  SMC  -actin:  ×
interpretation  of  the  references  to  color  in  this  ﬁgure  legend,  t
delayed  healing  with  coronary  endothelial  dysfunction  [5,6]
might  be  related  to  the  ﬁbrin  thrombus  formation.  Recently,
it  has  been  reported  that  the  other  cause  of  late  ISR  is
neoatherosclerosis  that  formed  in  the  stent  [2,7,8]. Thus,
there  is  also  a  possibility  that  retrieved  ﬁbrin  in  this  case  had
been  formed  during  a  previous  rupture  of  neoatherosclerosis
that  formed  in  the  stent  [2,7]. In  fact,  TCFA  was  recognized
in  the  short  segment  of  the  restenotic  tissue  suggesting  the
existence  of  neoatherosclerosis.  On  the  other  hand,  Sawada
et  al.  [9]  recently  reported  that  some  subclinical  intra-stent
thrombi  might  eventually  result  in  drug-eluting  stent  (DES)
b
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b
c Smooth  muscle  cells  were  not  detected  in  this  material.  (For
ader  is  referred  to  the  web  version  of  this  article.)
SR  and  some  restenosed  DES  neointima  might  be  conﬁgured
y  thrombi.  This  possibility  leads  to  the  hypothesis  that  the
YP2C19*2  polymorphism  is  associated  with  DES  restenosis
s  well  as  intra-stent  thrombus  through  a  poor  response  to
lopidogrel.  Although  the  patient  had  taken  both  aspirin  and
iclopidine,  drug  resistance  should  also  be  considered.
To  date,  there  are  no  OCT  criteria  for  organized  throm-
us  and  ﬁbrinoid  corresponding  with  histological  validation
10].  In  this  very  late  ISR  after  SES,  we  speculated  that  low
ackscatter  backward  with  a  superﬁcial  high  signal  ﬁbrous
ap,  where  stent  struts  were  identiﬁed  by  OCT  and  low
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choic  plaque  by  IVUS  might  suggest  ﬁbrin  thrombus.  Special
taining  and  immunohistological  study  showed  that  there
as  no  massive  deposition  of  proteoglycans  or  smooth  mus-
le  cells.  Because  all  restenotic  tissue  could  not  be  retrieved
n  this  case,  it  is  impossible  to  determine  the  OCT  and  IVUS
eatures  of  a  ﬁbrin  thrombus  deﬁnitely.
onclusions
he  present  case  indicates  that  ﬁbrin  formation  is  related
o  very  late  ISR.  The  OCT  and  IVUS  ﬁndings  of  this  case  were
emonstrated.
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